National Research Corp Files 8-K on Financials

Ticker: NRC · Form: 8-K · Filed: Oct 25, 2024 · CIK: 70487

National Research CORP 8-K Filing Summary
FieldDetail
CompanyNational Research CORP (NRC)
Form Type8-K
Filed DateOct 25, 2024
Risk Levellow
Pages2
Reading Time3 min
Sentimentneutral

Sentiment: neutral

Topics: financial-reporting, 8-k

TL;DR

NRC filed an 8-K on Oct 25th detailing financial results and condition.

AI Summary

National Research Corporation (NRC) filed an 8-K on October 25, 2024, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits, with the earliest reported event date being October 25, 2024. NRC is incorporated in Delaware and headquartered in Lincoln, Nebraska.

Why It Matters

This 8-K filing provides an update on National Research Corporation's financial performance and condition, which is crucial information for investors to assess the company's health and future prospects.

Risk Assessment

Risk Level: low — This filing is a routine 8-K reporting financial information and does not indicate any unusual or high-risk events.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to report on the Results of Operations and Financial Condition of National Research Corporation, and it includes Financial Statements and Exhibits.

When was the earliest event reported in this filing?

The earliest event reported in this filing was on October 25, 2024.

In which state is National Research Corporation incorporated?

National Research Corporation is incorporated in Delaware.

What is the business address of National Research Corporation?

The business address of National Research Corporation is 1245 Q Street, Lincoln, Nebraska 68508.

What is the telephone number for National Research Corporation?

The telephone number for National Research Corporation is (402) 475-2525.

Filing Stats: 654 words · 3 min read · ~2 pages · Grade level 12.5 · Accepted 2024-10-25 17:04:14

Filing Documents

02

Item 2.02 Results of Operations and Financial Condition. On October 25, 2024, National Research Corporation, a Delaware corporation (the "Company"), issued a press release announcing its financial and operating results for the third quarter ended September 30, 2024. A copy of the press release is furnished as Exhibit 99.1 to this report and is incorporated by reference herein.

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits. EXHIBIT NUMBER EXHIBIT DESCRIPTION 99.1 National Research Corporation press release announcing its financial and operating results for the third quarter ended September 30, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). The information contained in Items 2.02 and 9.01 of this report and the exhibits hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended (the "Securities Act"), or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. The information in Items 2.02 and 9.01 of this report and the exhibits hereto may contain "forward-looking statements" within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act and such statements are subject to the safe harbor created by those sections and the Private Securities Litigation Reform Act of 1995, as amended. Such statements are made based on the current beliefs and expectations of the Company's management and are subject to significant risks and uncertainties. Actual results or events may differ from those anticipated by forward-looking statements. Please refer to the paragraph at the end of the attached press release and various disclosures by the Company in its press releases, stockholder reports, and filings with the Securities and Exchange Commission for information concerning risks, uncertainties, and other factors that may affect future results. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NATIONAL RESEARCH CORPORATION (Registrant) Date: October 25, 2024 By: /s/ Linda Stacy Linda Stacy Secretary, Principal Financia

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing